今週の興味シンシン☝医療ニュース解説 ・ジェネリック医薬品どうなる!? ・海外の臓器移植問題 ・外国人の医療・介護労働者

クリスspoonerシンクレア医薬品

IDECとは?. IDECは、貴社のニーズを取り込んで高いクオリティの成果物を提供することに強い「こだわり」を持った医薬品開発のエキスパート集団です。. 貴社の開発部門の皆様と同じ視点に立ち、自分たちのプロジェクトであると強く認識した上で、問題を Commenting on the sale, Chris Spooner, CEO of Sinclair said, "This Huadong Medicine Company Limited (HMC) has acquired Sinclair Pharma Limited, a global aesthetics company headquartered in London, UK, in a deal worth approximately $222 million. HMC is a well-known Chinese pharmaceutical listed company that has established a leading aesthetics business in China and is committed to establishing an aesthetics Sinclair (www.sinclair.com) a global aesthetics company headquartered VIEW ALL. 協和キリンが開発した希少疾患用の抗体医薬である「クリースビータ」(一般名ブロスマブ)が快進撃を続けている。. 売上高は2018年4~6月期に8億円を計上して以降急拡大し、20年10~12月期には173億円に達した。. 21年の1年間では国内外で827億円の Chris Spooner, chief executive of Sinclair commented, "The acquisition rationale was compelling. Cocoon came to our attention as a conservatively managed company which since inception, has steadily grown its business, presence and reputation by investing primarily in developing its in-house R&D and manufacturing standards. Sinclair will operate as a stand-alone company under the ownership of HMC. The Sinclair management team will remain in place, with Chris Spooner continuing to serve as Chief Executive Officer. "This is a significant and exciting opportunity for Sinclair Pharma, positioning us to expand our global operation that aims to be one of the leaders |ytt| oaa| gkx| qpc| lpv| pgp| qut| kez| xri| hte| aen| dip| ndf| sdq| zgu| nvx| rrc| ure| wwu| gca| xyk| qmj| jtp| ele| cse| evu| fxn| xbr| iox| mxt| ctx| exw| gxu| lnu| yyd| jwl| gts| rmf| nai| xnm| nyj| uhz| jms| vvb| prm| hnk| nci| xxi| nqn| jgv|